{"id":"W2885345548","doi":"10.1007/s10637-018-0627-4","title":"Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor","year":2018,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Rash; Medicine; Pharmacokinetics; Toxicity; Pharmacology; Bioavailability; Adverse effect; In vivo; Mucositis; Population; Internal medicine; Gastroenterology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001854124,0.0001595057,0.0001455697,0.0000639598,0.0000940528,0.00003703958,0.0001527076,0.0001101132,0.00005942881],"category_scores_gemma":[0.00008983214,0.0001639275,0.00002509884,0.0001528708,0.0002704027,0.00002617414,0.00007541383,0.00006334379,0.00001206998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001835617,"about_ca_system_score_gemma":0.0003324785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001092402,"about_ca_topic_score_gemma":0.00005066179,"domain_scores_codex":[0.9988139,0.00007841698,0.0002995128,0.0003999325,0.0002452578,0.0001629902],"domain_scores_gemma":[0.9991001,0.00001349178,0.0001783775,0.0002815106,0.0002476968,0.0001787627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001213315,0.0003001494,0.003802563,0.00001222772,0.00003692665,0.000001157607,0.0006381525,0.00000645989,0.9906979,0.0001093259,0.001457142,0.002816705],"study_design_scores_gemma":[0.00286627,0.002876919,0.005032455,0.00003567571,0.00003584476,0.000005925884,0.0002095925,0.0003327271,0.9702883,0.0003105719,0.01773229,0.0002734308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998628,0.00007682932,0.0003440565,0.0002516286,0.0002147023,0.0002797544,0.00006845008,0.00001858045,0.0001179643],"genre_scores_gemma":[0.996139,0.00001033267,0.0009544548,0.0005739321,0.001074285,0.00001990474,0.0004961841,0.00002610717,0.0007057802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02040956,"threshold_uncertainty_score":0.668477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02063008807820533,"score_gpt":0.2880444537127292,"score_spread":0.2674143656345239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}